Want to see NATR full AI Analyst Report?
Top Page
Nature's Sunshine Products
(NASDAQ:NATR)
Select Model
Select Model
Rating:57Neutral
Price Target:
$13.00
▼(-9.03% Downside)
Action:Reiterated
Date:08/07/26
The score is held back primarily by weakened cash-flow conversion (despite revenue growth and strong gross margins) and bearish technical momentum. A conservative balance sheet and constructive digital/margin progress from the earnings call provide support, while valuation appears reasonable but not compelling without a dividend yield.
Positive Factors
Digital customer growth and retention
Rapid digital sales and customer growth, combined with materially higher lifetime value for autoship users, can improve customer retention and revenue quality. Expanding subscription behavior also gives the company a more repeatable channel that may reduce reliance on traditional distributor activity over the next several quarters.
Negative Factors
Lowered sales and EBITDA outlook
Reducing both revenue and EBITDA guidance indicates that near-term operating expectations have weakened, with foreign exchange and China softness affecting the outlook. Lower guidance reduces confidence in the pace of earnings growth and makes execution of the company’s longer-term expansion plan more demanding.
Read all positive and negative factors
Positive Factors
Negative Factors
Digital customer growth and retention
Rapid digital sales and customer growth, combined with materially higher lifetime value for autoship users, can improve customer retention and revenue quality. Expanding subscription behavior also gives the company a more repeatable channel that may reduce reliance on traditional distributor activity over the next several quarters.
Read all positive factors
Nature's Sunshine Products (NATR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$223.64M
Dividend Yield5.48%
Average Volume (3M)125.68K
Price to Earnings (P/E)12.5
Beta (1Y)0.37
Revenue Growth6.77%
EPS Growth34.53%
CountryUS
Employees806
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)1.02
Shares Outstanding17,595,520
10 Day Avg. Volume113,408
30 Day Avg. Volume125,684
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)2.41
Price to Sales (P/S)0.81
P/FCF Ratio13.47
Enterprise Value/Market Cap1.51
Enterprise Value/Revenue0.69
Enterprise Value/Gross Profit0.94
Enterprise Value/Ebitda8.03
Forecast
1Y Price Target
$30.50Price Target Upside113.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.18
Revenue Forecast (FY)$507.70M
Nature's Sunshine Products Business Overview & Revenue Model
Company Description
Nature's Sunshine Products, Inc. is a natural health and wellness enterprise that primarily manufactures and distributes a wide array of nutritional supplements and personal care products. The company's operational reach spans several continents, ...
How the Company Makes Money
Nature's Sunshine primarily makes money by selling its branded nutritional and personal care products. Its revenue model is centered on product sales through (1) a direct selling network of independent distributors who purchase products for person...
Nature's Sunshine Products Earnings Call Summary
Earnings Call Date:Aug 06, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 05, 2026
Earnings Call Sentiment Neutral
The call presented a mixed but constructive picture: the company delivered record Q2 sales, strong digital momentum, notable margin expansion and maintained a clean balance sheet and zero debt, while also announcing experienced senior hires and an ambitious 'Vision for Growth.' Offsetting these positives were a material decline in China, lower full‑year guidance (sales and EBITDA), a shift to negative operating cash flow in the quarter, continued pressure in the core direct selling business in North America, and near‑term SG&A increases to fund growth initiatives. Management framed key negatives (China, FX) as addressable and emphasized strategic investments to accelerate long‑term growth.Positive Updates
Record Second Quarter Net Sales
Net sales of $117.0M in Q2, the strongest second quarter in company history; +2% year-over-year (or +4% excluding foreign exchange).
Negative Updates
Significant China Sales Decline
China sales down 20% YoY, a reversal from recent >30% growth, attributed to operational issues; management expects issues to be short term but the decline materially impacted APAC results.
Read all updates
Q2-2026 Updates
Positive
Negative
Record Second Quarter Net Sales
Net sales of $117.0M in Q2, the strongest second quarter in company history; +2% year-over-year (or +4% excluding foreign exchange).
Read all positive updates
Company Guidance
Management lowered full-year net sales guidance to $490–$500 million (down from $500–$515 million) and cut full-year EBITDA guidance to $48–$52 million (from $50–$54 million); they expect gross margin to average in the low‑ to mid‑73% range for the remainder of 2026 and quarterly SG&A to run about $45–$47 million, while Q2 reported net sales were $117 million with adjusted EBITDA of $11.3 million, digital sales on track for about $50 million by year‑end (digital +26% in Q2, new customers +26%, autoship = 36% of web orders, social commerce +177% with 60% autoship), volume incentives at 30.6% of sales, cash and equivalents of $82.5 million with zero debt, net cash used by operations of $1.1 million (vs. $6.9 million provided prior year), and 113,000 shares repurchased for ~$2.5 million leaving $14.8 million remaining in the buyback program.Nature's Sunshine Products Financial Statement Overview
Summary
Income Statement
68
Positive
Balance Sheet
82
Very Positive
Cash Flow
44
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 492.02M | 480.14M | 454.36M | 445.32M | 421.91M | 444.08M |
| Gross Profit | 359.98M | 347.72M | 324.69M | 321.13M | 299.76M | 328.62M |
| EBITDA | 42.16M | 43.75M | 32.79M | 32.09M | 26.46M | 43.23M |
| Net Income | 18.10M | 19.52M | 7.70M | 15.08M | -390.00K | 28.85M |
Balance Sheet | ||||||
| Total Assets | 259.82M | 261.15M | 240.85M | 249.77M | 229.78M | 258.87M |
| Cash, Cash Equivalents and Short-Term Investments | 82.50M | 93.89M | 84.70M | 82.37M | 60.03M | 86.18M |
| Total Debt | 21.43M | 18.90M | 14.20M | 14.92M | 19.18M | 22.99M |
| Total Liabilities | 90.51M | 99.59M | 79.86M | 90.23M | 82.73M | 97.47M |
| Stockholders Equity | 169.32M | 161.55M | 155.31M | 154.06M | 142.91M | 158.20M |
Cash Flow | ||||||
| Free Cash Flow | 18.09M | 28.84M | 14.33M | 30.75M | -6.92M | 27.94M |
| Operating Cash Flow | 27.36M | 35.32M | 25.30M | 41.23M | 710.00K | 34.61M |
| Investing Cash Flow | -15.44M | -6.48M | -10.97M | -10.48M | -7.63M | -6.61M |
| Financing Cash Flow | -9.79M | -23.77M | -9.90M | -7.96M | -16.25M | -31.72M |
Nature's Sunshine Products Technical Analysis
Negative
14.29
Price Trends
14.27
Negative
17.57
Negative
21.21
Negative
Market Momentum
-0.50
Negative
32.75
Neutral
53.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NATR, the sentiment is Negative. The current price of 14.29 is above the 20-day moving average (MA) of 12.80, above the 50-day MA of 14.27, and below the 200-day MA of 21.21, indicating a bearish trend. The MACD of -0.50 indicates Negative momentum. The RSI at 32.75 is Neutral, neither overbought nor oversold. The STOCH value of 53.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NATR.
Nature's Sunshine Products Risk Analysis
Nature's Sunshine Products disclosed 25 risk factors in its most recent earnings report. Nature's Sunshine Products reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Nature's Sunshine Products Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | $75.28M | 14.95 | 15.25% | 3.18% | -20.10% | -49.17% | |
57 Neutral | $223.64M | 12.46 | 11.00% | 5.48% | 6.77% | 34.53% | |
55 Neutral | $1.43B | 8.51 | -32.15% | 1.80% | 5.52% | -50.47% | |
47 Neutral | $276.22M | -12.39 | -4.16% | ― | 1.57% | -166.61% | |
40 Underperform | $7.66M | -0.36 | -33.23% | ― | 9.08% | -52.59% |
* Consumer Defensive Sector Average
NATR
Nature's Sunshine Products
12.71
-2.02
-13.71%
HLF
Herbalife
13.61
4.89
56.08%
NAII
Natural Alternatives International
1.22
-1.44
-54.14%
USNA
USANA Health
14.95
-6.26
-29.51%
LFVN
LifeVantage
5.98
-2.79
-31.79%
Nature's Sunshine Products Corporate Events
Business Operations and StrategyExecutive/Board ChangesStock BuybackFinancial Disclosures
Nature’s Sunshine Names Ruth Perkins as New CFO
Neutral
Aug 6, 2026
On August 4, 2026, Nature’s Sunshine’s board appointed Ruth Perkins as Executive Vice President and Chief Financial Officer, effective September 1, 2026, while Jon Lanoy remains Principal Accounting Officer. Perkins, a veteran of Est&#...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.